Biointron is excited to announce our participation in the Chinese Antibody Society 2024 Annual Meeting on May 11, 2024, in Cambridge, MA, USA. This premier event, themed "Beyond Borders: Advancements in Antibody-Based Therapeutics in Uncharted Territories," promises to showcase the latest developments in antibody therapeutics, with a focus on discovery, development, and manufacturing innovations.

Case 1: Tag-Free Vaccine Protein. During the generation of stable cell lines, cells are selected and screened to identify clones that stably express the protein of interest at desired levels. This case study illustrates the successful generation of a tag-free vaccine protein.

VHHは、単一ドメイン抗体（シングルドメイン抗体）またはナノボディとも呼ばれ、アルパカ、ラマ、ラクダなどのラクダ科動物に見られる重鎖抗体から得られる最小の抗原結合断片です。1993年に初めて発見され、VHH抗体断片は、治療薬、診断、研究ツールにおいて特に有利な独自の特性を持っています。